Hawaii provider recognized with HIMSS Davies Award

Hilo Medical Center of Hilo, Hawaii, has been named a 2015 HIMSS Enterprise Davies Award recipient.

Issued since 1994, the HIMSS Nicholas E. Davies Award of Excellence recognizes outstanding achievement of organizations that have utilized health IT to substantially improve patient outcomes while achieving return on investment. The Davies Awards program promotes EHR-enabled improvement in patient outcomes through sharing of case studies and lessons learned across a wide range of efforts, including implementation strategies, workflow design, best practice development and adherence, and patient engagement that have improved both financial and care outcomes.

Hilo Medical Center (HMC) is a part of the East Hawai’i Region of the Hawai’i Health Systems Corporation (HHSC), serving as a safety-net hospital for two critical access hospitals, Hale Ho’ola Hamakua and Ka’u Hospital, according to a release. The East Hawai’i Region also includes nine outpatient clinics with specialties. HMC is a 276-bed facility with137 acute beds, 20-bed behavioral health facility, and 119-bed, long-term care facility. Overall, 72 percent of HMC's patients have Medicare or Medicaid insurance.

“As hospitals struggle with reduced reimbursement, hospital leaders are utilizing technology and data to maximize care delivery efficiency,” said Jonathan French, director of quality and patient safety at HIMSS. “Hilo Medical Center staff members could not make a cell phone call from inside their facility in 2009, yet by leveraging the data generated by health information technology Hilo has saved millions of dollars through more efficient care delivery and revenue cycle management."

Health IT also has enabled standardized protocols to reduce hospital acquired infections and reduce the mortality rates of patients admitted with pneumonia. 

Hilo Medical Center will be recognized at the 2016 Annual HIMSS Conference & Exhibition, February 29-March 4, 2016, in Las Vegas. 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.